


Healthcare Industry NewsFeed
HSMN NewsFeed - 17 Jan 2020
SkinMedica(R) Launches New Instant Bright Eye Cream For Immediate, Visible Results
SkinMedica(R) Launches New Instant Bright Eye Cream For Immediate, Visible Results
HSMN NewsFeed - 17 Jan 2020
DURECT Corporation Announces Outcome of FDA Advisory Committee Meeting for POSIMIR(R)
DURECT Corporation Announces Outcome of FDA Advisory Committee Meeting for POSIMIR(R)
HSMN NewsFeed - 16 Jan 2020
Frazier Healthcare Partners Announces Multiple Promotions on its Life Sciences Team
Frazier Healthcare Partners Announces Multiple Promotions on its Life Sciences Team
HSMN NewsFeed - 16 Jan 2020
ANI Pharmaceuticals Announces FDA Approval of Potassium Citrate Extended-Release Tablets USP
ANI Pharmaceuticals Announces FDA Approval of Potassium Citrate Extended-Release Tablets USP
HSMN NewsFeed - 15 Jan 2020
Vyaire Medical's Compatible, Reusable MX40(TM) Telemetry Adapter Now Available
Vyaire Medical's Compatible, Reusable MX40(TM) Telemetry Adapter Now Available
HSMN NewsFeed - 13 Jan 2020
CNS Pharmaceuticals Licenses DNA-Binding Agent from MD Anderson, Doubling its Drug Pipeline
CNS Pharmaceuticals Licenses DNA-Binding Agent from MD Anderson, Doubling its Drug Pipeline
HSMN NewsFeed - 10 Jan 2020
ProciseDx(TM) Announces CE Mark for Point of Care Inflammatory Marker Assay
ProciseDx(TM) Announces CE Mark for Point of Care Inflammatory Marker Assay
HSMN NewsFeed - 9 Jan 2020
BioDirection(R), Inc. Appoints Dr. Jean-Luc Boulnois to its Board of Directors
BioDirection(R), Inc. Appoints Dr. Jean-Luc Boulnois to its Board of Directors
HSMN NewsFeed - 9 Jan 2020
Ionis Appoints Onaiza Cadoret-Manier As Chief Corporate Development and Commercial Officer
Ionis Appoints Onaiza Cadoret-Manier As Chief Corporate Development and Commercial Officer
HSMN NewsFeed - 9 Jan 2020
Omniome Closes $60 Million Series C Financing To Advance Novel Genomic Sequencing Platform
Omniome Closes $60 Million Series C Financing To Advance Novel Genomic Sequencing Platform
HSMN NewsFeed - 8 Jan 2020
Former Celgene Chairman and CEO Mark J. Alles Joins Antengene Board of Directors
Former Celgene Chairman and CEO Mark J. Alles Joins Antengene Board of Directors
HSMN NewsFeed - 8 Jan 2020
Revitope Oncology Appoints Steve Arkinstall, D.Phil., as Chief Executive Officer
Revitope Oncology Appoints Steve Arkinstall, D.Phil., as Chief Executive Officer
HSMN NewsFeed - 7 Jan 2020
HeartBeam Appoints Rich Ferrari and Marga Ortigas-Wedekind to its Board of Directors
HeartBeam Appoints Rich Ferrari and Marga Ortigas-Wedekind to its Board of Directors
HSMN NewsFeed - 7 Jan 2020
IFM Therapeutics Appoints Michael Cooke, Ph.D., as Chief Scientific Officer
IFM Therapeutics Appoints Michael Cooke, Ph.D., as Chief Scientific Officer
HSMN NewsFeed - 7 Jan 2020
IRRAS Provides US Launch Update, Product Portfolio Progress and Objectives for 2020
IRRAS Provides US Launch Update, Product Portfolio Progress and Objectives for 2020
HSMN NewsFeed - 6 Jan 2020
Antengene Corporation Appoints Former Celgene China GM John Chin as Chief Business Officer
Antengene Corporation Appoints Former Celgene China GM John Chin as Chief Business Officer
HSMN NewsFeed - 6 Jan 2020
Slayback Pharma announces investment of $50 million by The Everstone Group
Slayback Pharma announces investment of $50 million by The Everstone Group
HSMN NewsFeed - 6 Jan 2020
CARsgen Appoints Yong Fan as Senior Vice President of Global Regulatory Affairs
CARsgen Appoints Yong Fan as Senior Vice President of Global Regulatory Affairs
HSMN NewsFeed - 6 Jan 2020
Vascular Graft Solutions Acquires the Intellectual Property Developed by Kipsbay Medical Inc.
Vascular Graft Solutions Acquires the Intellectual Property Developed by Kipsbay Medical Inc.
